Edition:
United States

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

1.79USD
4:00pm EDT
Change (% chg)

$-0.06 (-3.24%)
Prev Close
$1.85
Open
$1.85
Day's High
$1.87
Day's Low
$1.78
Volume
55,415
Avg. Vol
128,022
52-wk High
$8.30
52-wk Low
$1.70

About

Aduro Biotech, Inc. is an immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, including cancer. The Company's product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes... (more)

Overall

Beta: --
Market Cap(Mil.): $762.55
Shares Outstanding(Mil.): 73.68
Dividend: --
Yield (%): --

Financials

  ADRO.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -1.57 -- --
ROI: -24.47 8.90 13.82
ROE: -42.02 10.04 15.24

BRIEF-Aduro Biotech And Novartis Present Results From Ongoing Phase 1B Study

* ADURO BIOTECH AND NOVARTIS PRESENT RESULTS FROM ONGOING PHASE 1B STUDY OF STING AGONIST ADU-S100 (MIW815) IN COMBINATION WITH ANTI-PD-1 MONOCLONAL ANTIBODY SPARTALIZUMAB (PDR001) IN PATIENTS WITH ADVANCED SOLID TUMORS OR LYMPHOMAS

Jun 02 2019

Earnings vs. Estimates